Sri Lanka proposals, reports & plans

in page functions

Approved proposals

All eligible countries are invited to submit proposals for Gavi support. 

Proposal for NVS – IPV support
Date of Gavi approval: 30 June 2014

Proposal for HSS support: Sri Lanka
Date of Gavi approval: 01 November 2007

Proposal for NVS - Hib support: Sri Lanka
Date of Gavi approval: 01 August 2007

Proposal for INS, NVS - HepB support: Sri Lanka
Date of Gavi approval: 01 October 2001

Annual progress reports

Countries receiving and implementing Gavi support submit annual progress reports to the monitoring team of the Independent Review Committee (IRC). Receipt of annual progress reports is a condition for continued support from Gavi. The IRC monitoring team assesses the reports and provides recommendations for approval to the Gavi Board. 

Comprehensive multi-year plans/Financial sustainability plans

The comprehensive multi-year plan (cMYP) is a single plan which consolidates several immunisation activities. It is a key planning and management tool for national immunisation programmes. It addresses global, national, and subnational immunisation objectives and strategies, and evaluates the costs and financing of the programme in line with the WHO-UNICEF Global Immunization Vision and Strategy 2006-2015. Gavi requires countries to submit a cMYP along with the standard proposal form when applying for Gavi support (ISS, INS, and NVS). In 2006, over 50 countries had developed cMYPs using the WHO-UNICEF cMYP guidelines and costing tool.
The cMYP replaces the financial sustainability plan (FSP), used to assess the funding challenges of a country's national immunisation programme within the broader health financing context and to describe the government’s approach to mobilising and effectively using resources to support medium- and long-term immunisation objectives. 

Country co-financing information sheets

The country-specific co-financing sheets provide up-to-date information on countries’ eligibility status, co-financing fulfilment and requirements. They also give a summary of government health expenditure, including immunisation financing.

Specifically, the sheets provide a history of the Gavi-supported vaccines introduced per country, the country’s co-financing payments to date and its co-financing requirements for the current year. In case the country has defaulted on its co-financing requirements, there is an overview of the co-financing arrears of the previous year. Finally, the sheets provide co-financing projections for the next five years based on our latest forecasts.

The information sheets are updated at least twice per year to account for new information on countries’ co-financing fulfilment (in the first quarter) and eligibility status (in the third quarter).

HSS evaluation

The HSS evaluation team visited several countries (in depth country studies) and conducted a number of country desk reviews (Country desk studies).

Decision Letters and Partnerships Agreements

The Decision Letter or Partnership Framework Agreement provides a summary of the details of the new approval or continuation of a Gavi window of support, following the independent review of a new application or annual progress report submitted by a country.

The joint appraisal report

The joint appraisal is an in-country, multi-stakeholder review of the implementation progress and performance of Gavi's vaccine and cash grant support to the country, and of its contribution to improved immunisation outcomes. The outcome of the appraisal is the completed "joint appraisal report" that captures Gavi grant performance as well as implementation challenges. The joint appraisal report informs discussions with national coordination mechanisms on areas where greater national investments and efforts, as well as technical support, are needed.

close icon

modal window here